| MolName | (E)-N-(2-hydroxy-5-piperidin-1-ylsulfonylphenyl)-3-(4-morpholin-4-ylsulfonylphenyl)prop-2-enamide |
| MolecularFormula | C24H29N3O7S2 |
| Smiles | Oc(ccc(S(N1CCCCC1)(=O)=O)c1)c1NC(/C=C/c(cc1)ccc1S(N1CCOCC1)(=O)=O)=O |
| InChI | InChI=1S/C24H29N3O7S2/c28-23-10-9-21(36(32,33)26-12-2-1-3-13-26)18-22(23)25-24(29)11-6-19-4-7-20(8-5-19)35(30,31)27-14-16-34-17-15-27/h4-11,18,28H,1-3,12-17H2,(H,25,29) |
| InChIK | WAHQOJJQCYYNCB-UHFFFAOYSA-N |
| TotalMolweight | 535.64 |
| Molweight | 535.64 |
| MonoisotopicMass | 535.144692 |
| CLogP | 2.0402 |
| CLogS | -2.503 |
| H Acceptors | 10 |
| H Donors | 2 |
| TotalSurfaceArea | 379.68 |
| Relative PSA | 0.29462 |
| PolarSurfaceArea | 150.08 |
| Druglikeness | 0.5846 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | |
| Shape Index | 0.58333 |
| Fragments | 1 |
| Non HAtoms | 36 |
| NonCHAtoms | 12 |
| Electronegative Atoms | 12 |
| Rotatable Bond | 5 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 13 |
| Symmetricatoms | 8 |
| Amides | 3 |
| StereoCon |
Click to Load Molecule:
1 - (E)-N-(2-hydroxy-5-piperidin-1-ylsulfonylphenyl)-3-(4-morpholin-4-ylsulfonylphenyl)prop-2-enamide | 2 - (E)-N-(2-hydroxy-5-piperidin-1-ylsulfonylphenyl)-3-(4-morpholin-4-ylsulfonylphenyl)prop-2-enamide